Literature DB >> 1311358

Analysis of intrastrain recombination in herpes simplex virus type 1 strain 17 and herpes simplex virus type 2 strain HG52 using restriction endonuclease sites as unselected markers and temperature-sensitive lesions as selected markers.

S M Brown1, J H Subak-Sharpe, J Harland, A R MacLean.   

Abstract

The viral and host factors involved in herpes simplex virus (HSV) recombination are little understood. To identify features of the process, recombination in HSV-1 and HSV-2 has been studied by analysing the segregation of unselected markers in the form of restriction endonuclease (RE) sites. By confining parental interactions to only one strain of virus of each serotype, restrictions imposed by non-homology are overcome and differential growth phenotypes can be discounted. The analysis of unselected and selected recombinants using RE sites in conjunction with temperature-sensitive mutations is consistent with (i) HSV being highly recombinogenic, (ii) parental and progeny molecules taking part in the process, (iii) the four genomic isomers participating in recombination, (iv) genome alignment being part of the recombination process and (v) cellular factors in conjunction with genome homology influencing the efficiency of recombination.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311358     DOI: 10.1099/0022-1317-73-2-293

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

1.  High-frequency intermolecular homologous recombination during herpes simplex virus-mediated plasmid DNA replication.

Authors:  Xinping Fu; Hua Wang; Xiaoliu Zhang
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

2.  Using HSV-1 genome phylogenetics to track past human migrations.

Authors:  Aaron W Kolb; Cécile Ané; Curtis R Brandt
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

3.  Herpes simplex virus type 1 alkaline nuclease is required for efficient processing of viral DNA replication intermediates.

Authors:  R Martinez; R T Sarisky; P C Weber; S K Weller
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

4.  Recombinants are isolated at high frequency following in vivo mixed ocular infection with two avirulent herpes simplex virus type 1 strains.

Authors:  R L Kintner; R W Allan; C R Brandt
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

5.  Herpes simplex virus type 1 recombination: the Uc-DR1 region is required for high-level a-sequence-mediated recombination.

Authors:  R E Dutch; B V Zemelman; I R Lehman
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

6.  Herpes simplex virus type 1 DNA replication is specifically required for high-frequency homologous recombination between repeated sequences.

Authors:  R E Dutch; V Bianchi; I R Lehman
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

7.  Interspecific recombination between two ruminant alphaherpesviruses, bovine herpesviruses 1 and 5.

Authors:  François Meurens; Günther M Keil; Benoît Muylkens; Sacha Gogev; Frédéric Schynts; Sandra Negro; Laetitia Wiggers; Etienne Thiry
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Excision of DNA fragments corresponding to the unit-length a sequence of herpes simplex virus type 1 and terminus variation predominate on one side of the excised fragment.

Authors:  K Umene
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

9.  Catalysis of strand exchange by the HSV-1 UL12 and ICP8 proteins: potent ICP8 recombinase activity is revealed upon resection of dsDNA substrate by nuclease.

Authors:  Nina B Reuven; Smaranda Willcox; Jack D Griffith; Sandra K Weller
Journal:  J Mol Biol       Date:  2004-09-03       Impact factor: 5.469

10.  Herpes simplex virus type 1 variant a sequence generated by recombination and breakage of the a sequence in defined regions, including the one involved in recombination.

Authors:  K Umene
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.